2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Upper Respiratory Infections: new trials by email Literature Review of Upper Respiratory Infections trials Research Report on Upper Respiratory Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI IFF flavor 316 282, Paracetamol, Pseudoephedrine - Upper Respiratory Infections | Phase 3 | Completed | Novartis | 56 | 2012-05-01 | 2013-08-07 |
| Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI) IFF flavor 316 282, Paracetamol , Phenylephrine, Guaifenesin - Upper Respiratory Infections | Phase 3 | Completed | Novartis | 51 | 2012-03-01 | 2013-11-11 |
Respiratory Tract Infections (2)
Infections (2) · Respiratory Tract Diseases (2)
Acetaminophen (2) · Guaifenesin (1) · Phenylephrine (1) · Pseudoephedrine (1)
Novartis (2)
Canada (2)